Trypanosome class II transcription pre-initiation complex

锥虫 II 类转录前起始复合物

基本信息

  • 批准号:
    7590870
  • 负责人:
  • 金额:
    $ 36.37万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2009
  • 资助国家:
    美国
  • 起止时间:
    2009-05-15 至 2011-04-30
  • 项目状态:
    已结题

项目摘要

The trypanosomatid parasites Trypanosoma brucei, T. cruzi and Leishmania spp. (Tritryp) cause the major human diseases African Sleeping Sickness, Chagas’ disease, and Leishmaniasis, respectively. Drugs for these diseases are few and toxic and parasite resistance to these drugs is on the rise. Thus, it becomes increasingly important to find new anti-parasitic targets and develop new therapeutic strategies. All trypanosomatids depend on the same unusual mode of gene expression involving polycistronic transcription of protein coding genes and trans splicing of nuclear pre-mRNA. Of central importance to this process is the parasite-specific spliced leader (SL) RNA from which the 5’ terminal part is cleaved and fused to the 5’ end of each mRNA. Since SL RNA is consumed in this process, the parasites crucially depend on continuously strong SL RNA synthesis throughout their life cycle. We have recently identified and characterized several proteins in T. brucei which are essential for SL RNA gene transcription. These include extremely divergent homologues of the general transcription factors TFIIA, TFIIB, TFIIH, and a candidate TFIIE suggesting that the parasites form a class II transcription pre-initiation complex (PIC) at the SL RNA gene (SLRNA) promoter to recruit RNA polymerase II for accurate transcription initiation. The extraordinary level of sequence divergence between these proteins and their mammalian orthologues, which prevented their identification in the completed Tritryp genome projects, indicates that the trypanosome PIC deviates substantially from its human counterpart. To explore this possibility, we will functionally characterize the PIC which forms at the SLRNA promoter. This will include RNA interference, in vitro transcription experiments and DNA-protein interaction assays to evaluate the identified proteins’ importance for parasite growth and role in SLRNA transcription. Finally, we will analyze if the parasites use PIC formation to recruit RNA polymerase II to their long tandem arrays of protein coding genes. Chromatin immunoprecipitation in combination with deep sequencing will identify non-SLRNA PIC formation sites in the T. brucei genome. Together, these experiments may uncover unique and essential structural and/or biochemical features in a fundamentally important process, namely the recruitment of RNA polymerase II to DNA.
布氏锥虫Trypanosoma brucei、T.克氏利什曼原虫属(Leishmania spp.)(Tritryp)分别引起主要的人类疾病非洲昏睡病、恰加斯病和利什曼病。治疗这些疾病的药物很少,而且有毒和寄生虫对这些药物的抗药性正在上升。因此,寻找新的抗寄生虫靶点和开发新的治疗策略变得越来越重要。所有锥虫都依赖于相同的不寻常的基因表达模式,包括蛋白质编码基因的多顺反子转录和核前mRNA的反式剪接。对该过程至关重要的是寄生虫特异性剪接前导(SL)RNA,其5'末端部分被切割并融合到每个mRNA的5'末端。由于SL RNA在此过程中被消耗,寄生虫在其整个生命周期中至关重要地依赖于持续强大的SL RNA合成。我们最近鉴定和表征了T.它们是布鲁氏菌SL RNA基因转录所必需的。这些包括一般转录因子TFIIA、TFIIB、TFIIH和候选TFIIE的极其不同的同源物,这表明寄生虫在SL RNA基因(SLRNA)启动子处形成II类转录前起始复合物(PIC),以募集RNA聚合酶II用于准确的转录起始。这些蛋白质和它们的哺乳动物直向同源物之间的序列差异非常大,这使得它们无法在完成的Tritryp基因组计划中被识别出来,这表明锥虫PIC与其人类对应物有很大的差异。为了探索这种可能性,我们将在SLRNA启动子处形成的PIC的功能特征。这将包括RNA干扰,体外转录实验和DNA-蛋白质相互作用测定,以评估所鉴定的蛋白质对寄生虫生长的重要性和SLRNA转录中的作用。最后,我们将分析寄生虫是否使用PIC形成来将RNA聚合酶II招募到其蛋白质编码基因的长串联阵列中。染色质免疫沉淀结合深度测序将鉴定T.布鲁氏菌基因组总之,这些实验可能会发现一个根本重要的过程中,即RNA聚合酶II的招聘DNA的独特和必要的结构和/或生化特征。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

ARTHUR GUNZL其他文献

ARTHUR GUNZL的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('ARTHUR GUNZL', 18)}}的其他基金

The essential role of cyclin-dependent kinase CRK9 in trypanosome pre-mRNA processing
细胞周期蛋白依赖性激酶 CRK9 在锥虫前 mRNA 加工中的重要作用
  • 批准号:
    10570982
  • 财政年份:
    2021
  • 资助金额:
    $ 36.37万
  • 项目类别:
The essential role of cyclin-dependent kinase CRK9 in trypanosome pre-mRNA processing
细胞周期蛋白依赖性激酶 CRK9 在锥虫前 mRNA 加工中的重要作用
  • 批准号:
    10362703
  • 财政年份:
    2021
  • 资助金额:
    $ 36.37万
  • 项目类别:
The essential role of cyclin-dependent kinase CRK9 in trypanosome pre-mRNA processing
细胞周期蛋白依赖性激酶 CRK9 在锥虫前 mRNA 加工中的重要作用
  • 批准号:
    10219576
  • 财政年份:
    2021
  • 资助金额:
    $ 36.37万
  • 项目类别:
RNA polymerase II transcription in trypanosomes
锥虫中的 RNA 聚合酶 II 转录
  • 批准号:
    8190182
  • 财政年份:
    2009
  • 资助金额:
    $ 36.37万
  • 项目类别:
RNA polymerase II transcription in trypanosomes
锥虫中的 RNA 聚合酶 II 转录
  • 批准号:
    8653521
  • 财政年份:
    2009
  • 资助金额:
    $ 36.37万
  • 项目类别:
RNA polymerase II transcription in trypanosomes
锥虫中的 RNA 聚合酶 II 转录
  • 批准号:
    8827661
  • 财政年份:
    2009
  • 资助金额:
    $ 36.37万
  • 项目类别:
Trypanosome class II transcription pre-initiation complex
锥虫 II 类转录前起始复合物
  • 批准号:
    7843594
  • 财政年份:
    2009
  • 资助金额:
    $ 36.37万
  • 项目类别:
RNA polymerase II transcription in trypanosomes
锥虫中的 RNA 聚合酶 II 转录
  • 批准号:
    8259403
  • 财政年份:
    2009
  • 资助金额:
    $ 36.37万
  • 项目类别:
RNA polymerase II transcription in trypanosomes
锥虫中的 RNA 聚合酶 II 转录
  • 批准号:
    8447031
  • 财政年份:
    2009
  • 资助金额:
    $ 36.37万
  • 项目类别:
Multifunctional class I transcription in T. brucei
布氏锥虫中的多功能 I 类转录
  • 批准号:
    8414838
  • 财政年份:
    2004
  • 资助金额:
    $ 36.37万
  • 项目类别:

相似海外基金

The catalytic core of the proteasome as a drug target to treat Human African Trypanosomiasis
蛋白酶体的催化核心作为治疗非洲人类锥虫病的药物靶点
  • 批准号:
    10511408
  • 财政年份:
    2022
  • 资助金额:
    $ 36.37万
  • 项目类别:
A One Health approach to investigating the ecology of East African trypanosomiasis in Malawian wildlife
调查马拉维野生动物中东非锥虫病生态学的“同一个健康”方法
  • 批准号:
    476178
  • 财政年份:
    2022
  • 资助金额:
    $ 36.37万
  • 项目类别:
    Studentship Programs
The catalytic core of the proteasome as a drug target to treat Human African Trypanosomiasis
蛋白酶体的催化核心作为治疗非洲人类锥虫病的药物靶点
  • 批准号:
    10677879
  • 财政年份:
    2022
  • 资助金额:
    $ 36.37万
  • 项目类别:
Multi-target approach to rational design of novel therapeutics for human African trypanosomiasis
多目标方法合理设计非洲人类锥虫病新疗法
  • 批准号:
    10466942
  • 财政年份:
    2021
  • 资助金额:
    $ 36.37万
  • 项目类别:
Multi-target approach to rational design of novel therapeutics for human African trypanosomiasis
多目标方法合理设计非洲人类锥虫病新疗法
  • 批准号:
    10296873
  • 财政年份:
    2021
  • 资助金额:
    $ 36.37万
  • 项目类别:
Multi-target approach to rational design of novel therapeutics for human African trypanosomiasis
多目标方法合理设计非洲人类锥虫病新疗法
  • 批准号:
    10706306
  • 财政年份:
    2021
  • 资助金额:
    $ 36.37万
  • 项目类别:
Reducing and replacing the animal cost of functional genetics in African trypanosomiasis
减少和替代非洲锥虫病功能遗传学的动物成本
  • 批准号:
    NC/W001144/1
  • 财政年份:
    2021
  • 资助金额:
    $ 36.37万
  • 项目类别:
    Research Grant
Development of new drug for African trypanosomiasis based on elucidation of the mechanism of antiprotozoal action by ribavirin.
基于利巴韦林抗原虫作用机制的阐明,开发治疗非洲锥虫病的新药。
  • 批准号:
    21K18230
  • 财政年份:
    2021
  • 资助金额:
    $ 36.37万
  • 项目类别:
    Grant-in-Aid for Challenging Research (Pioneering)
Development of a novel control measure for African trypanosomiasis based on the blocking of lifecycle progression
基于生命周期进展阻断的非洲锥虫病新型控制措施的开发
  • 批准号:
    20K07467
  • 财政年份:
    2020
  • 资助金额:
    $ 36.37万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Drug-diagnostic co-development in Tropical Medicine, combating Human African Trypanosomiasis
热带医学药物诊断联合开发,抗击非洲人类锥虫病
  • 批准号:
    18KK0454
  • 财政年份:
    2019
  • 资助金额:
    $ 36.37万
  • 项目类别:
    Fund for the Promotion of Joint International Research (Fostering Joint International Research (A))
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了